thiophenes has been researched along with cyclin d1 in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| A'Hern, R; Detre, S; Dowsett, M; Johnston, SR; Riddler, S; Salter, J | 1 |
| Hellinger, N; Jing, Y; Monks, A; Sausville, EA; Waxman, S; Xia, L; Zelent, A | 1 |
| Abe, Y; Aizawa, Y; Kamal, FA; Kodama, M; Ma, M; Nagai, Y; Palaniyandi, SS; Prakash, P; Tachikawa, H; Veeraveedu, PT; Watanabe, K; Yamaguchi, K | 1 |
| Jalink, K; Mancini, MA; Michalides, R; Neefjes, J; Rondaij, M; Sharp, ZD; Zwart, W | 1 |
| Bai, S; Lu, J; Sheng, G; Wang, C; Wang, L; Wang, Y | 1 |
| Cogoi, S; Shchekotikhin, AE; Xodo, LE; Zorzet, S | 1 |
| Bertoni, F; Carrassa, L; Chilà, R; Damia, G; Kwee, I; Lupi, M; Restelli, V; Rinaldi, A | 1 |
| Alcaraz, Y; García-Becerra, R; García-Revilla, MA; Hernández-Borja, F; Mercado-Sánchez, I; Ordaz-Rosado, D; Santos-Martínez, N; Vazquez, MA; Villegas Gómez, C | 1 |
| Chen, W; Du, R; Gao, C; He, Z; Teng, H; Wang, H; Wu, D; Zhao, Y; Zong, Y | 1 |
9 other study(ies) available for thiophenes and cyclin d1
| Article | Year |
|---|---|
Comparison of the selective estrogen receptor modulator arzoxifene (LY353381) with tamoxifen on tumor growth and biomarker expression in an MCF-7 human breast cancer xenograft model.
Topics: Animals; Apoptosis; Biomarkers, Tumor; Breast Neoplasms; Cell Cycle Proteins; Cell Division; Cell Line, Tumor; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p27; Female; Humans; Mice; Mice, Nude; Piperidines; Protein Biosynthesis; Proteins; Receptors, Estrogen; Receptors, Progesterone; Selective Estrogen Receptor Modulators; Tamoxifen; Thiophenes; Trefoil Factor-1; Tumor Suppressor Proteins; Xenograft Model Antitumor Assays | 2003 |
Benzodithiophenes induce differentiation and apoptosis in human leukemia cells.
Topics: Animals; Antioxidants; Apoptosis; Cell Differentiation; Cyclin D1; Dose-Response Relationship, Drug; HL-60 Cells; Humans; Leukemia, Erythroblastic, Acute; Leukemia, Experimental; Leukemia, Promyelocytic, Acute; Mice; Structure-Activity Relationship; Thiophenes; Tretinoin | 2005 |
Chymase inhibition reduces the progression to heart failure after autoimmune myocarditis in rats.
Topics: Animals; Atrial Natriuretic Factor; Autoimmune Diseases; Cardiomyopathy, Dilated; Chymases; Collagen Type III; Cyclin D1; Disease Progression; Enzyme Inhibitors; Heart Failure; Histamine; Humans; Macaca mulatta; Male; Myocarditis; Rats; Rats, Inbred Lew; Rats, Sprague-Dawley; Sulfonamides; Survival Rate; Thiophenes; Transforming Growth Factor beta1 | 2007 |
Resistance to antiestrogen arzoxifene is mediated by overexpression of cyclin D1.
Topics: Cell Line, Tumor; Cell Proliferation; Cyclin D1; Drug Resistance; Estrogen Receptor alpha; Estrogen Receptor Modulators; Fluorescence Resonance Energy Transfer; Gene Expression Regulation; HeLa Cells; Humans; Microscopy, Confocal; Models, Chemical; Piperidines; Thiophenes | 2009 |
Combined effects of FLT3 and NF-κB selective inhibitors on acute myeloid leukemia in vivo.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Cell Line, Tumor; Cyclin D1; fms-Like Tyrosine Kinase 3; Humans; Leukemia, Myeloid, Acute; Male; Mice; Mice, Inbred BALB C; Mice, Nude; NF-kappa B; Nuclear Receptor Co-Repressor 2; Proto-Oncogene Proteins c-bcl-2; Sesquiterpenes; Thiophenes; Tumor Burden; Xenograft Model Antitumor Assays | 2012 |
Potent Apoptotic Response Induced by Chloroacetamidine Anthrathiophenediones in Bladder Cancer Cells.
Topics: Acetamides; Alleles; Animals; Antineoplastic Agents; Apoptosis; Biological Transport; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Drug Design; G-Quadruplexes; G2 Phase Cell Cycle Checkpoints; Genes, ras; Humans; Mice; Substrate Specificity; Survival Analysis; Thiophenes; Urinary Bladder Neoplasms; Xenograft Model Antitumor Assays | 2015 |
Characterization of a mantle cell lymphoma cell line resistant to the Chk1 inhibitor PF-00477736.
Topics: Antineoplastic Agents; Benzodiazepinones; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Checkpoint Kinase 1; Cyclin D1; Dasatinib; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Humans; Lymphoma, Mantle-Cell; Molecular Targeted Therapy; Nuclear Proteins; Protein Kinase Inhibitors; Protein Kinases; Protein-Tyrosine Kinases; Pyrazoles; Pyrimidines; Pyrimidinones; Signal Transduction; src-Family Kinases; Thiophenes; Time Factors; Urea | 2015 |
Exploring novel capping framework: high substituent pyridine-hydroxamic acid derivatives as potential antiproliferative agents.
Topics: Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Epigenesis, Genetic; Female; Furans; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Humans; Male; Molecular Docking Simulation; PC-3 Cells; Pregnancy; Prostatic Neoplasms; Pyridines; Thiophenes; Tumor Suppressor Protein p53 | 2021 |
Topics: Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Ferroptosis; Imidazoles; Indoles; Molecular Structure; Pentacyclic Triterpenes; Sulfonamides; Thiophenes; Triterpenes | 2022 |